# FDA Inspection 594229 - DIAGAST - January 16, 2009

Source: https://www.globalkeysolutions.net/records/fda_inspections/diagast/13d2be9b-a45a-4b4e-b545-9ba5b9cb0204
Source feed: FDA_Inspections

> FDA Inspection 594229 for DIAGAST on January 16, 2009. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 594229
- Company Name: DIAGAST
- Inspection Date: 2009-01-16
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1236304 - 2024-04-19](https://www.globalkeysolutions.net/records/fda_inspections/diagast/d15ba283-2382-4e2b-ba78-de05c6b00630)
- [FDA Inspection 1012901 - 2017-02-21](https://www.globalkeysolutions.net/records/fda_inspections/diagast/2956b5db-20d5-4502-9e06-ef04d8783a89)
- [FDA Inspection 927715 - 2015-03-17](https://www.globalkeysolutions.net/records/fda_inspections/diagast/6ba90abc-9adc-435e-935b-99a482098334)
- [FDA Inspection 715544 - 2011-03-08](https://www.globalkeysolutions.net/records/fda_inspections/diagast/cc3a31a9-301f-494e-8fbe-7149d021c112)

Company: https://www.globalkeysolutions.net/companies/diagast/c0e0edce-1abe-473a-9127-8abb20d191a6

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d